Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2899 (LINC02899)
- Target
- LINC02899
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2899 (LINC02899) is a human long intergenic non-coding RNA (lincRNA), classified by its length (>200 nucleotides) and non-protein-coding nature, and does not overlap coding gene loci[1][3][7]. LINC02899, like other lincRNAs, is believed to be transcribed autonomously and may regulate gene expression through mechanisms such as remodeling chromatin, influencing genome architecture, acting in transcriptional regulation, and serving as an enhancer-associated transcript[3][7]. Its functions are likely context- and tissue-specific, but there is currently no direct, validated evidence for a role in disease, nor is it established as a therapeutic target, druggable protein, or clinical biomarker[1][3][7].
- Other names
- FLJ34836C5orf17LINC02899
02
Biological functions
Transcriptional regulationChromatin remodelingRNA stabilizationGenome architecture regulationEnhancer-associated activity
03
Disease associations
Other (no established associations with specific diseases or validated roles in cancer, inflammation, etc., although related lincRNAs may be linked to disease)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2899 (LINC02899).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2899 (LINC02899).